Merck 'disappointed' but bows to Brazil
For the first time, Brazil’s government has issued a compulsory license on a drug patent. Merck & Co - the drug’s manufacturer - has said it will try to work with the government, despite being “profoundly disappointed” by the decision.
To read more
Subscribe to Latin Lawyer
Subscribe and start reading now
Latin Lawyer is your definitive source of news, analysis, and research from the Latin American legal community. It keeps you up to speed with the issues and trends that matter and provides the data and tools you need to operate successfully.